La société bretonne Hemarina a clôturé une levée de fonds de 8 millions d’euros pour commercialiser son produit “HEMO2life”, destiné à améliorer la conservation des greffons.

Source: Hemarina relève 8 millions d’euros pour préserver les greffons, Sciences & Prospectives 

In english => http://hemarina.com/index.php?rex=19&ctn=pub_aff_breve.318#pub_aff_breve.318


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

Leave a Reply